Saeed Ahmed Mahar

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Safety and efficacy of Empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK); a randomized clinical trial”.

Safety and efficacy of Empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK); a randomized clinical trial

BMC Endocrine Disorders(2022)10.1186/s12902-022-01213-1

N/A

0.264DataRank · unranked

4 citations

Umar Yousaf Raja, Faisal Qureshi, Ali Asghar, Saeed Ahmed Mahar, Ibrar Ahmed +9 more

Safety and efficacy of Empagliflozin in Pakistani Muslim Patients with Type 2 Diabetes (SAFE-PAK); A Randomized Clinical Trial

Research Square(2022)10.21203/rs.3.rs-1798584/v1

N/A

0DataRank · unranked

1 citations

Umar Raja, Faisal Masood Qureshi, Ali Asghar, Saeed Ahmed Mahar, Ibrar Ahmed +9 more